Association of Serum Bilirubin with Heart Failure Events but Not Coronary Events in Patients with Left Ventricular Systolic Dysfunction: Data from the Beta-Blocker Evaluation of Survival Trial (BEST)
Publication
, Conference
Allen, L; Fiuzat, M; Davis, G; Felker, GM; Bristow, M
Published in: Journal of Cardiac Failure
August 2010
Duke Scholars
Published In
Journal of Cardiac Failure
DOI
ISSN
1071-9164
Publication Date
August 2010
Volume
16
Issue
8
Start / End Page
S65 / S65
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1110 Nursing
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Allen, L., Fiuzat, M., Davis, G., Felker, G. M., & Bristow, M. (2010). Association of Serum Bilirubin with Heart Failure Events but Not Coronary Events in Patients with Left Ventricular Systolic Dysfunction: Data from the Beta-Blocker Evaluation of Survival Trial (BEST). In Journal of Cardiac Failure (Vol. 16, pp. S65–S65). Elsevier BV. https://doi.org/10.1016/j.cardfail.2010.06.224
Allen, Larry, Mona Fiuzat, Gordon Davis, G Michael Felker, and Michael Bristow. “Association of Serum Bilirubin with Heart Failure Events but Not Coronary Events in Patients with Left Ventricular Systolic Dysfunction: Data from the Beta-Blocker Evaluation of Survival Trial (BEST).” In Journal of Cardiac Failure, 16:S65–S65. Elsevier BV, 2010. https://doi.org/10.1016/j.cardfail.2010.06.224.
Allen L, Fiuzat M, Davis G, Felker GM, Bristow M. Association of Serum Bilirubin with Heart Failure Events but Not Coronary Events in Patients with Left Ventricular Systolic Dysfunction: Data from the Beta-Blocker Evaluation of Survival Trial (BEST). In: Journal of Cardiac Failure. Elsevier BV; 2010. p. S65–S65.
Allen, Larry, et al. “Association of Serum Bilirubin with Heart Failure Events but Not Coronary Events in Patients with Left Ventricular Systolic Dysfunction: Data from the Beta-Blocker Evaluation of Survival Trial (BEST).” Journal of Cardiac Failure, vol. 16, no. 8, Elsevier BV, 2010, pp. S65–S65. Crossref, doi:10.1016/j.cardfail.2010.06.224.
Allen L, Fiuzat M, Davis G, Felker GM, Bristow M. Association of Serum Bilirubin with Heart Failure Events but Not Coronary Events in Patients with Left Ventricular Systolic Dysfunction: Data from the Beta-Blocker Evaluation of Survival Trial (BEST). Journal of Cardiac Failure. Elsevier BV; 2010. p. S65–S65.
Published In
Journal of Cardiac Failure
DOI
ISSN
1071-9164
Publication Date
August 2010
Volume
16
Issue
8
Start / End Page
S65 / S65
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1110 Nursing
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology